- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02167529
Quality of Life After Thyroidectomy (ThyrQol) (ThyrQol)
August 9, 2017 updated by: Nantes University Hospital
A Prospective, Multicenter and Observational Trial to Evaluate Evolution of Quality of Life (SF-36) After Total Thyroidectomy.
The purpose of this study is to evaluate the evolution of quality of life and voice function with different questionnaires (VIH, SF36) before and after total thyroidectomy.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
890
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49933
- Angers University Hospital
-
La Roche sur Yon, France, 85925
- CHD La Roche sur Yon
-
Limoges, France, 87042
- Limoges University Hospital
-
Lyon, France, 69000
- Lyon University Hospital
-
Nancy, France, 54511
- Nancy University Hospital
-
Nantes, France, 44093
- Nantes University Hospital
-
Paris, France, 75013
- La Pitié-Salpétrière - AP-HP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
A prospective, non randomized, open, multicenter trial to evaluate quality of life (SF 36) and voice function (VHI questionnaire) before and after totalthyroidectomy
Description
Inclusion Criteria:
- Adult over 18 years
- Notice to total thyroidectomy
- Thyroidectomy under cervicotomy or videoscopy
- Existence of a written informed consent of the patient
- Affiliation to a social security
- Possible follow-up for 6 months
Exclusion Criteria:
- Impossibility for the patient to complete the forms
- Impossibility to follow the patient patient with serious disease which impact the quality of life
- Medullary thyroid cancers
- Preoperative examination of vocal cords (if performed) finding a violation of the vocal cords
- Lack of monitoring possible during the 6 months after surgery
- Pregnant women or during lactation
- Minors and adults under guardianship
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluate the differences in terms of impact on quality of life among patients without sequelae 6 months after thyroidectomy (laryngeal paralysis or hypoparathyroidism) and patients with hypoparathyroidism. (SF36 v1,3, self-administered questionnaire)
Time Frame: Evaluation at 6 months
|
Evaluation at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Evaluation of the impact of post thyroidectomy laryngeal paralysis on the quality of life (SF36 v1,3, self-administered questionnaire)
Time Frame: Evaluation at 2 and 6 months
|
Evaluation at 2 and 6 months
|
|
Evaluation of difficulties voice after total thyroidectomy (with or without laryngeal complication) (VIH questionnaire)
Time Frame: Evaluation at 2 and 6 months
|
Evaluation at 2 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eric MIRALLIE, Pr, Nantes University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 6, 2014
Primary Completion (Actual)
December 31, 2016
Study Completion (Actual)
August 1, 2017
Study Registration Dates
First Submitted
June 17, 2014
First Submitted That Met QC Criteria
June 17, 2014
First Posted (Estimate)
June 19, 2014
Study Record Updates
Last Update Posted (Actual)
August 11, 2017
Last Update Submitted That Met QC Criteria
August 9, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- RC11_0194
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Thyroidectomy
-
Genexine, Inc.SymyooCompletedTotal Thyroidectomy | Near-total ThyroidectomyKorea, Republic of
-
Istanbul UniversityUnknownPhoniatric Evaluation of Total ThyroidectomyTurkey
-
King Edward Medical UniversityMayo Hospital LahoreNot yet recruitingPostoperative Symptomatic Hypocalcemia Following Total ThyroidectomyPakistan
-
TC Erciyes UniversityEnrolling by invitationTotal ThyroidectomyTurkey
-
Johns Hopkins UniversityRecruitingTotal ThyroidectomyUnited States
-
Al Safwa University CollegeCompletedHypocalcemia After Total ThyroidectomyTunisia
-
Zagazig UniversityCompleted
-
Gulab Devi HospitalCompletedHypocalcemia | Hypocalcemia After Total ThyroidectomyPakistan
-
G. Hatzikosta General HospitalUnknownHypocalcemia After Total ThyroidectomyGreece
-
Ospedale Regina ApostolorumCompletedBenign Thoroid Disease Requiring Total ThyroidectomyItaly